Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
58 hedge funds and large institutions have $269M invested in Flexion Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 4 closing their positions.
350% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 4
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
32% more funds holding
Funds holding: 44 → 58 (+14)
13% more capital invested
Capital invested by funds: $238M → $269M (+$31.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$16.6M |
| 2 |
Jennison Associates
New York
|
+$5.92M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4.53M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.77M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.3M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.91M |
| 3 |
DM
Deerfield Management
New York
|
-$2.02M |
| 4 |
VAM
Visium Asset Management
New York
|
-$1.83M |
| 5 |
BC
Broadfin Capital
New York
|
-$1.51M |
FLXN Hedge Fund Activity: Q1 2015 in Review
58 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2015, worth a combined $269M — up 13% from $238M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FLXN positions and 4 closed out — a net gain of 14 holders — while 22 added to existing stakes and 12 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $16.6M. The largest seller was Fidelity Investments, exiting entirely with an estimated $26.3M sold.
- 58 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2015, up from 44 in Q4 2014.
- Funds reported $269M of Flexion Therapeutics, Inc. stock for Q1 2015, up 13% quarter-over-quarter.
- 18 funds opened new Flexion Therapeutics, Inc. positions in Q1 2015 and 4 closed out, a net change of +14 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2015 was Gilder Gagnon Howe & Co, an estimated $16.6M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2015 was Fidelity Investments, an estimated $26.3M sold.
Based on aggregated 13F filings for Q1 2015.